Prosensa harvests $78M as biotech IPOs continue to sizzle

John Carroll

picked the right day to price its IPO. The Dutch rang up the offering at $ 13 a share, at the top of the range, raising $ 78 million after bumping the number of shares on offer to 6 million. The stock will trade on Nasdaq as "RNA."

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS